BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Górski A, Jończyk-Matysiak E, Łusiak-Szelachowska M, Międzybrodzki R, Weber-Dąbrowska B, Borysowski J. The Potential of Phage Therapy in Sepsis. Front Immunol 2017;8:1783. [PMID: 29312312 DOI: 10.3389/fimmu.2017.01783] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Abbaszadeh F, Leylabadlo HE, Alinezhad F, Feizi H, Mobed A, Baghbanijavid S, Baghi HB. Bacteriophages: cancer diagnosis, treatment, and future prospects. J Pharm Investig 2021;51:23-34. [DOI: 10.1007/s40005-020-00503-x] [Reference Citation Analysis]
2 Iszatt JJ, Larcombe AN, Chan HK, Stick SM, Garratt LW, Kicic A. Phage Therapy for Multi-Drug Resistant Respiratory Tract Infections. Viruses 2021;13:1809. [PMID: 34578390 DOI: 10.3390/v13091809] [Reference Citation Analysis]
3 Huber I, Potapova K, Kuhn A, Schmidt H, Hinrichs J, Rohde C, Beyer W. 1st German Phage Symposium-Conference Report. Viruses 2018;10:E158. [PMID: 29596346 DOI: 10.3390/v10040158] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 Jault P, Leclerc T, Jennes S, Pirnay JP, Que YA, Resch G, Rousseau AF, Ravat F, Carsin H, Le Floch R, Schaal JV, Soler C, Fevre C, Arnaud I, Bretaudeau L, Gabard J. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Lancet Infect Dis 2019;19:35-45. [PMID: 30292481 DOI: 10.1016/S1473-3099(18)30482-1] [Cited by in Crossref: 236] [Cited by in F6Publishing: 124] [Article Influence: 59.0] [Reference Citation Analysis]
5 Kwiatek M, Parasion S, Nakonieczna A. Therapeutic bacteriophages as a rescue treatment for drug-resistant infections - an in vivo studies overview. J Appl Microbiol 2020;128:985-1002. [PMID: 31778593 DOI: 10.1111/jam.14535] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
6 Niu M, Chen P. Crosstalk between gut microbiota and sepsis. Burns Trauma 2021;9:tkab036. [PMID: 34712743 DOI: 10.1093/burnst/tkab036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wienhold SM, Lienau J, Witzenrath M. Towards Inhaled Phage Therapy in Western Europe. Viruses 2019;11:E295. [PMID: 30909579 DOI: 10.3390/v11030295] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
8 Lex JR, Koucheki R, Stavropoulos NA, Michele JD, Toor JS, Tsoi K, Ferguson PC, Turcotte RE, Papagelopoulos PJ. Megaprosthesis anti-bacterial coatings: A comprehensive translational review. Acta Biomater 2022;140:136-48. [PMID: 34879295 DOI: 10.1016/j.actbio.2021.11.045] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Kaabi SAG, Musafer HK. An experimental mouse model for phage therapy of bacterial pathogens causing bacteremia. Microb Pathog 2019;137:103770. [PMID: 31586662 DOI: 10.1016/j.micpath.2019.103770] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
10 Naureen Z, Malacarne D, Anpilogov K, Dautaj A, Camilleri G, Cecchin S, Bressan S, Casadei A, Albion E, Sorrentino E, Beccari T, Dundar M, Bertelli M. Comparison between American and European legislation in the therapeutical and alimentary bacteriophage usage. Acta Biomed 2020;91:e2020023. [PMID: 33170166 DOI: 10.23750/abm.v91i13-S.10815] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Venturini C, Petrovic Fabijan A, Fajardo Lubian A, Barbirz S, Iredell J. Biological foundations of successful bacteriophage therapy. EMBO Mol Med 2022;:e12435. [PMID: 35620963 DOI: 10.15252/emmm.202012435] [Reference Citation Analysis]
12 Żaczek M, Górski A, Skaradzińska A, Łusiak-szelachowska M, Weber-dąbrowska B. Phage penetration of eukaryotic cells: practical implications. Future Virology 2019;14:745-60. [DOI: 10.2217/fvl-2019-0110] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review. Front Microbiol 2019;10:539. [PMID: 30988669 DOI: 10.3389/fmicb.2019.00539] [Cited by in Crossref: 266] [Cited by in F6Publishing: 228] [Article Influence: 88.7] [Reference Citation Analysis]
14 Cuomo P, Papaianni M, Fulgione A, Guerra F, Capparelli R, Medaglia C. An Innovative Approach to Control H. pylori-Induced Persistent Inflammation and Colonization. Microorganisms 2020;8:E1214. [PMID: 32785064 DOI: 10.3390/microorganisms8081214] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
15 Lin RC, Sacher JC, Ceyssens PJ, Zheng J, Khalid A, Iredell JR; Australian Phage Biobanking Network. Phage Biobank: Present Challenges and Future Perspectives. Curr Opin Biotechnol 2021;68:221-30. [PMID: 33581425 DOI: 10.1016/j.copbio.2020.12.018] [Reference Citation Analysis]
16 Górski A, Borysowski J, Międzybrodzki R. Sepsis, Phages, and COVID-19. Pathogens 2020;9:E844. [PMID: 33076482 DOI: 10.3390/pathogens9100844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Leontyev АE, Pavlenko IV, Kovalishena ОV, Saperkin NV, Tulupov АА, Beschastnov VV. Application of Phagotherapy in the Treatment of Burn Patients (Review). Sovrem Tekhnologii Med 2021;12:95-103. [PMID: 34795985 DOI: 10.17691/stm2020.12.3.12] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Serwer P, Wright ET, Lee JC. High murine blood persistence of phage T3 and suggested strategy for phage therapy. BMC Res Notes 2019;12:560. [PMID: 31488211 DOI: 10.1186/s13104-019-4597-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
19 Liu AC, Patel K, Vunikili RD, Johnson KW, Abdu F, Belman SK, Glicksberg BS, Tandale P, Fontanez R, Mathew OK, Kasarskis A, Mukherjee P, Subramanian L, Dudley JT, Shameer K. Sepsis in the era of data-driven medicine: personalizing risks, diagnoses, treatments and prognoses. Brief Bioinform 2020;21:1182-95. [PMID: 31190075 DOI: 10.1093/bib/bbz059] [Reference Citation Analysis]
20 Kropinski AM. Bacteriophage research - What we have learnt and what still needs to be addressed. Res Microbiol 2018;169:481-7. [PMID: 29777837 DOI: 10.1016/j.resmic.2018.05.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
21 Borysowski J, Przybylski M, Międzybrodzki R, Owczarek B, Górski A. The effects of bacteriophages on the expression of genes involved in antimicrobial immunity*. Postepy Hig Med Dosw 2019;73:414-20. [DOI: 10.5604/01.3001.0013.4081] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
22 Górski A, Międzybrodzki R, Łobocka M, Głowacka-Rutkowska A, Bednarek A, Borysowski J, Jończyk-Matysiak E, Łusiak-Szelachowska M, Weber-Dąbrowska B, Bagińska N, Letkiewicz S, Dąbrowska K, Scheres J. Phage Therapy: What Have We Learned? Viruses 2018;10:E288. [PMID: 29843391 DOI: 10.3390/v10060288] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 13.5] [Reference Citation Analysis]
23 Petrovic Fabijan A, Khalid A, Maddocks S, Ho J, Gilbey T, Sandaradura I, Lin RC, Ben Zakour N, Venturini C, Bowring B, Iredell JR. Phage therapy for severe bacterial infections: a narrative review. Med J Aust 2020;212:279-85. [PMID: 31587298 DOI: 10.5694/mja2.50355] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
24 Górski A, Międzybrodzki R, Jończyk-Matysiak E, Weber-Dąbrowska B, Bagińska N, Borysowski J. Perspectives of Phage-Eukaryotic Cell Interactions to Control Epstein-Barr Virus Infections. Front Microbiol 2018;9:630. [PMID: 29666617 DOI: 10.3389/fmicb.2018.00630] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]